Arkolith/Insider Trading/ANAB/Form 4

Orwin John A

DirectorANAPTYSBIO, INC (ANAB) · full profile →Form 4 · filed Apr 22, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Disposed to issuer(D)3K—$03K
Apr 20, 2026Grant(A)3K—$03K
Apr 20, 2026Disposed to issuer(D)11K—$011K
Apr 20, 2026Grant(A)11K—$011K
Apr 20, 2026Disposed to issuer(D)17K—$017K
Apr 20, 2026Grant(A)17K—$017K
Apr 20, 2026Disposed to issuer(D)17K—$017K
Apr 20, 2026Grant(A)17K—$017K
Apr 20, 2026Disposed to issuer(D)8K—$08K
Apr 20, 2026Grant(A)8K—$08K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477384-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML